Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1908001
Max Phase: Preclinical
Molecular Formula: C20H12O
Molecular Weight: 268.31
Molecule Type: Small molecule
Associated Items:
ID: ALA1908001
Max Phase: Preclinical
Molecular Formula: C20H12O
Molecular Weight: 268.31
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 11-Hydroxybenzo[A]Pyrene
Synonyms from Alternative Forms(1):
Canonical SMILES: Oc1cc2cccc3ccc4cc5ccccc5c1c4c32
Standard InChI: InChI=1S/C20H12O/c21-17-11-14-6-3-5-12-8-9-15-10-13-4-1-2-7-16(13)20(17)19(15)18(12)14/h1-11,21H
Standard InChI Key: JATVWVYVLWEYNL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 268.31 | Molecular Weight (Monoisotopic): 268.0888 | AlogP: 5.44 | #Rotatable Bonds: 0 |
Polar Surface Area: 20.23 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.17 | CX Basic pKa: | CX LogP: 4.97 | CX LogD: 4.96 |
Aromatic Rings: 5 | Heavy Atoms: 21 | QED Weighted: 0.29 | Np Likeness Score: 0.53 |
1. Tukey RH, Strassburg CP.. (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease., 40 (1): [PMID:10836148] [10.1146/annurev.pharmtox.40.1.581] |
Source(1):